PATENT CLAIM ANALYSIS

Application Number: 16117375
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "648000"]

Abstract:
An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.

Claim (Index 16):
The method of  claim 15  wherein the buffering agent is selected from the group consisting of meglumine, glycine, sodium carbonate, calcium carbonate, sodium bicarbonate, phosphate buffer, magnesium hydroxide, and combinations thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.58974
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14973759', '15823636', '15387317', '14697891', '12638070']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7948601989675309
- 35 USC 102 Novelty (BERT): 0.4949726391634539
- Combined Prediction Score: 0.7648714429871233
- Mean Citation Score: 215.47927400000003
- Max Citation Score: 270.94516
- Similarity Product: 231.42735547613864

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test